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Abstract
Aging is associated with diminished cardiac function in males. Cardiac excitation-contraction coupling in ventricular myocytes involves Ca 
influx via the Ca current (ICa) and Ca release from the sarcoplasmic reticulum, which occur predominantly at t-tubules. Caveolin-3 regulates 
t-tubular ICa, partly through protein kinase A (PKA), and both ICa and caveolin-3 decrease with age. We therefore investigated ICa and t-tubule 
structure and function in cardiomyocytes from male wild-type (WT) and caveolin-3-overexpressing (Cav-3OE) mice at 3 and 24 months of age. 
In WT cardiomyocytes, t-tubular ICa-density was reduced by ~50% with age while surface ICa density was unchanged. Although regulation by 
PKA was unaffected by age, inhibition of caveolin-3-binding reduced t-tubular ICa at 3 months, but not at 24 months. While Cav-3OE increased 
cardiac caveolin-3 protein expression ~2.5-fold at both ages, the age-dependent reduction in caveolin-3 (WT ~35%) was preserved in transgenic 
mice. Overexpression of caveolin-3 reduced t-tubular ICa density at 3 months but prevented further ICa loss with age. Measurement of Ca release 
at the t-tubules revealed that the triggering of local Ca release by t-tubular ICa was unaffected by age. In conclusion, the data suggest that the 
reduction in ICa density with age is associated with the loss of a caveolin-3-dependent mechanism that augments t-tubular ICa density.
Keywords: Caveolin-3, Excitation-contraction coupling, Ca signaling
It is generally recognized that aging is associated with changes in 
normal cardiac function, although the cellular mechanisms underly-
ing this remodeling remain unclear (1,2). It is becoming apparent 
that the effects of age on the heart differ between the sexes (2). For 
example, while the contractile amplitude of ventricular myocytes 
isolated from male mouse hearts were reduced by age, age did not 
affect contractility of myocytes from female mouse hearts (3,4). In 
male ventricular myocytes, reduced L-type Ca current (ICa) density 
(4–7), altered ryanodine receptor (RyR) activity and slowed sarco-
plasmic reticulum (SR) Ca uptake have been suggested to contribute 
to the effects of physiological aging on excitation-contraction (E-C) 
coupling (8–11). Transverse (t-) tubules, invaginations of the surface 
membrane that are central to E-C coupling (12–14), are known to 
be labile (15), and changes in both t-tubule structure and function 
have been implicated in the impaired contractility observed in heart 
failure (16,17). However, the effect of aging on t-tubule structure 
and function is unknown.
The cholesterol-binding membrane protein caveolin-3 (Cav-3) 
has been suggested to contribute to t-tubule development (18,19) and 
also plays an important role in the localization of a striking variety of 
ion channels, transporters, and signaling proteins at the sarcolemma 
of cardiac myocytes (20–22), including the localization of L-type 
Ca channels (LTCCs; and thus ICa), Na-Ca exchange (NCX) and β2-
adrenoceptors, to the t-tubules (23–27). It has also been suggested that 
Cav-3 plays a role in the constitutive regulation of ICa at the t-tubules 
(25). Recent studies have shown that Cav-3 expression declines with 
Head1=Head2=Head1=Head2/Head1
Head2=Head3=Head2=Head3/Head2
age (28,29) and a role has been suggested for this decrease in Cav-3 
expression in the development of the aged phenotype (30).
We have, therefore, investigated the effect of age on t-tubule 
structure, ICa, and intracellular Ca transients, in myocytes from male 
wild-type (WT) mice and whether cardiac-specific over-expression of 
Cav-3 (31) protects against the effects of aging on the heart.
Methods
Further details of experimental methods are provided in the 
Supplementary Material available online (https://academic.oup.com/
biomedgerontology).
Animals
All procedures were performed in accordance with UK legislation. 
Transgenic mice with cardiac myocyte-specific over-expression of 
Cav-3 (Cav-3OE) were generated using animals from Tsutsumi et al. 
(31) and WT C57Bl/6 littermates. Animals were kept in temperature-
controlled rooms with ad libitum access to food and water.
Myocyte Isolation
Ventricular myocytes were isolated from the hearts of 3- and 
24-month-old male WT and Cav-3OE mice. Animals were injected 
with heparin (500 I.U., i.p.) and 5 minutes later killed by cervical dis-
location, the heart rapidly excised and myocytes isolated using our 
standard methods (26), and used on the day of isolation.
Solutions
The standard perfusion solution used in these experiments con-
tained (in mM): 133 NaCl, 5 KCl, 1 MgSO4, 1 CaCl2, 1 Na2HPO4, 
10 D-glucose, 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), pH 7.4 (NaOH). During electrophysiological recordings, 
KCl was substituted with CsCl to inhibit K currents and the pip-
ette solution contained (in mM): 110 CsCl, 20 TEACl, 0.5 MgCl2, 
5 MgATP, 5 BAPTA, 10 HEPES, 0.4 GTP-Tris, pH 7.2 (CsOH). All 
experiments were performed at room temperature. Where stated, 1 
μM of TAT-tagged Cav-3 scaffolding domain (C3SD) peptide (32,33) 
was used as described previously (25). The C3SD peptide is thought 
to disrupt binding of Cav-3 to its partner proteins at the scaffolding 
domain (32,33). While the role of the caveolin scaffolding domain in 
interactions with partner proteins has been questioned (34,35), pre-
treatment of cardiac myocytes with the peptide has previously been 
shown to inhibit Cav-3-dependent signaling compared with cells 
treated with scrambled control peptide (25,32,33).
Statistics
Data are expressed as mean ± SEM. Paired and unpaired t tests 
or Mann–Whitney test and one- or two-way analysis of variance 
(ANOVA) were used with the Bonferroni post-hoc test where applic-
able. Current density-voltage relationship curves were analyzed with 
two-way repeated measures (RM) ANOVA with Bonferroni post-
hoc test. The limit of statistical confidence was p < .05. Sample sizes 
(n/N) represent the numbers of cells and animals, respectively.
Results
Effect of Age and Cav-3OE on Cell Morphology
Aging from 3 to 24 months was associated with cellular hypertrophy 
in cardiac myocytes. Figure  1A shows mean data for length and 
width of myocytes isolated from WT and Cav-3OE mice at 3 and 
24 months of age. Age was associated with an increase in cell length 
(p < .001, two-way ANOVA) and cell width (p < .001, two-way 
ANOVA) with the increase in length and width being greater in the 
Cav-3OE than in WT mice (increase in length: WT ~5%, Cav-3OE 
~19% and width: WT ~11%, Cav-3OE ~22%). Cell capacitance, an 
electrical measure of cell surface membrane area, also increased with 
age in both WT and Cav-3OE cells (by ~24% and 55%, respect-
ively; p < .001, two-way ANOVA, Figure  1A). There was no dif-
ference in cell width between WT and Cav-3OE myocytes at either 
3 or 24 months, whereas at 24 months, but not at 3 months, Cav-
3OE myocytes were longer than WT (p < .05, two-way ANOVA, 
Bonferroni post hoc test). Mean cell width, length, and capacitance 
of detubulated cells are shown in Figure 1B.
The relationship between cell membrane area and cell size 
is difficult to predict due to the presence of t-tubules. We there-
fore constructed a simple geometric model cell to examine the 
expected relationship between membrane area and cell size, assum-
ing no changes in t-tubule density (for details, see Supplementary 
Material). In brief, myocyte geometry was approximated by a closed 
elliptical cylinder, with t-tubules approximated by round cylinders 
Figure 1. Effect of age and Cav-3 over-expression on cell size and t-tubule 
organization. (A) Mean cell length, width and capacitance measured in intact 
myocytes from wild-type (WT) (black bars) and Cav-3OE (gray bars) mice 
at 3 months and 24 months of age. Two-way analysis of variance (ANOVA) 
(age, genotype) tests yielded results as follows. Length: age p < .001, 
genotype ns, interaction p < .01. Width: age p < .001, genotype ns, 
interaction ns. Capacitance: age p < .001, genotype ns, interaction p < .05. 
(B) Corresponding data from detubulated (DT) myocytes. Length: age ns, 
genotype p = .03, interaction ns. Width: age p = .027, genotype ns, interaction 
ns. Capacitance: age ns, genotype ns, interaction p = .049. Asterisks indicate 
*p < .05, **p < .01, and ***p < .001 (Bonferroni corrected post-hoc test). 
n/N indicated on bars. (C) Representative confocal images of t-tubules 
labeled with di-8-ANEPPs. Scale bar shows 10  μm. (D) Mean t-tubule 
skeleton density. (E) Mean percentage of t-tubules that were oriented along 
the long-axis of the cell (“longitudinal”). Asterisks and n/N as in A and B.
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invaginating the cell. The model predicted a 22% increase in total 
membrane area of WT myocytes and a 55% increase in total mem-
brane area of Cav-3OE myocytes simply as a result of the measured 
age-dependent hypertrophy, which agrees well with the observed 
increases in cell capacitance with age in the two genotypes (24% 
and 55%, respectively).
To examine the effects of age and Cav-3OE on t-tubule struc-
ture, live myocytes were stained with di-8-ANEPPS to label lipid 
membranes continuous with the surface sarcolemma. Representative 
confocal images show modest changes in t-tubule organization with 
age (Figure 1C). Quantification of the t-tubule skeleton showed 
that aging in WT and OE myocytes was associated with a 12% and 
14% reduction in t-tubule density (p < .01, two-way ANOVA), re-
spectively (Figure 1D), with no significant effect of Cav-3OE. This 
slight decrease in t-tubule density with age was not accompanied 
by changes in tubule orientation, as the proportion of longitudinal 
tubules remained the same (Figure 1E). Cav-3OE did not appear to 
alter tubule orientation over this age range.
Taken together, these data suggest that aging is accompanied by 
an increase in cell width and capacitance, with a small decrease in 
t-tubule density. While the age-related hypertrophy was augmented 
slightly in Cav-3OE myocytes, Cav-3 over-expression had little effect 
on t-tubule morphology at either age and did not ameliorate the 
effect of age on cell and t-tubule morphology.
Effect of Age and Cav-3OE on ICa
Since Cav-3 has been implicated in localization of ICa to the t-tubules 
(25,27), we investigated ICa distribution and regulation with age and 
Cav-3 over-expression. ICa was recorded from intact (Figure  2A, 
top) and DT (Figure 2A, bottom) myocytes from 3-month (left pan-
els) and 24-month (right panels) WT hearts. The corresponding ICa 
density-voltage relationships (Figure 2B) show that ICa density was 
reduced with age. Absolute ICa in WT myocytes was not significantly 
different at the two ages (Supplementary Table 1), which suggests 
that the decrease in ICa density with age was primarily due to the 
increase in membrane area (by 24%, measured as cell capacitance) 
without a commensurate increase in LTCC number. Assuming no 
change in absolute ICa, either at the t-tubules or at the surface sarco-
lemma, the geometric model predicts that the increase in total mem-
brane area due to cellular hypertrophy would be associated with a 
greater decrease in ICa density at the t-tubules than at the surface 
membrane (Supplementary Figure S1, G and H). To test this idea, 
ICa was recorded from DT 3-month and 24-month WT myocytes. ICa 
density was reduced following DT at the two ages, consistent with 
the predominant localization of ICa to the t-tubules but there was 
no significant difference in ICa density in DT cells at the two ages 
(Figure 2B; Supplementary Table S2). Thus, in WT myocytes, t-tubu-
lar ICa density was decreased by ~50% (p < .002, t test) while that at 
the cell surface was unchanged with age (Figure 2C). This compares 
with the 23% decrease in t-tubular ICa density and 15% decrease in 
surface sarcolemmal ICa density predicted by the model as a result of 
cellular hypertrophy alone. Thus, the data show that age was associ-
ated with a loss of ICa density from the t-tubules specifically, an effect 
that cannot be accounted for by cellular hypertrophy alone.
In intact Cav-3OE myocytes, both absolute ICa and cell capaci-
tance increased with age. In consequence, unlike WT myocytes, ICa 
density in intact Cav-3OE myocytes was unchanged with age (two-
way RM ANOVA, age ns, interaction ns; Figure 2D, E). In DT myo-
cytes, cell capacitance and ICa density were not significantly different 
with age. Figure  2F shows calculated ICa density at the t-tubules, 
compared to that at the cell surface, and shows that unlike in WT 
myocytes, t-tubular ICa density in Cav-3OE myocytes was unchanged 
with age. This contrasts with the decrease predicted by the model on 
the basis of simple geometric considerations, and suggests mainten-
ance of ICa as a result of Cav-3 OE.
These data also show that over-expression of Cav-3 has a dif-
ferent effect on ICa in 3-month and 24-month myocytes. ICa density 
in intact myocytes was reduced by over-expression of Cav-3 at 
3 months but not at 24 months. Comparison of Figure 2C and F 
shows that the major effects of over-expression of Cav-3 were to 
decrease t-tubular ICa at 3 months, and inhibit further age-associated 
decrease in t-tubular (and thus, whole cell) ICa density, with little 
effect at the cell surface.
Figure  2. Effect of age and Cav-3 over-expression on ICa density. (A) 
Representative records of ICa elicited by step depolarizations to −30, −20, −10, 
and 0 mV recorded from intact (top panels) or detubulated (DT, bottom panels) 
myocytes isolated from 3- and 24-month-old wild-type (WT) mice. Scale 
bars show 100 ms. (B) Mean ICa density-voltage relationships recorded from 
3-month intact (closed circles) and DT (open circles) myocytes, and 24-month 
intact (closed squares) and DT (open squares) myocytes from WT and Cav-3OE 
animals. Analysis with two-way repeated measures analysis of variance (RM 
ANOVA) yielded: intact myocytes, age p < .01, voltage p < .001, interaction p < 
.001; DT myocytes, age ns, voltage p < .001, interaction ns. (C) Mean ICa density 
at 0 mV for intact and DT (“surface”) myocytes, with estimated t-tubular ICa 
density in 3- (gray) and 24-month (black) WT myocytes. ** indicates p < .01 by 
Student’s t test. (D) Corresponding representative records of ICa intact and DT 
myocytes isolated from 3- and 24-month-old Cav-3OE mice, to the same time 
scale as panel A. (E) Mean ICa density-voltage relationships recorded from Cav-
3OE myocytes, using the same key as panel B. Analysis with two-way RM 
ANOVA yielded: intact myocytes, age ns, voltage p < .001, interaction ns; DT 
myocytes, age ns, voltage p < .001, interaction p < .001. (F) Mean ICa density 
at 0 mV for whole cell and DT Cav-3OE myocytes, with estimated t-tubular 
ICa density. Dashed horizontal line in (C) and (F) corresponds to t-tubular ICa 
density of Cav-3OE myocytes (−9.3 pA/pF). B and E: *p < .05, **p < .01, and 
***p < .001 (Bonferroni corrected post-hoc test), C: *p < .05 (Student’s t test).
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To clarify the effect of Cav-3 over-expression at 3 months, par-
ticularly whether the reduction in ICa was Cav-3-dependent rather 
than a result of transgenic modification, Cav-3 scaffolding domain 
peptide (C3SD peptide) was used (25,32). C3SD peptide interferes 
with the interaction of Cav-3 with its binding partners, thus reduc-
ing the effect of Cav-3 over-expression. Figure  3 shows the effect 
of C3SD on ICa density measured at 0 mV in 3 months (panel A) 
and 24 months (panel B), WT and Cav-3OE myocytes. While ap-
plication of C3SD decreased ICa density in 3 months WT myocytes, 
as shown previously in rat (25), it increased ICa density in 3-month 
Cav-3OE myocytes. In contrast, C3SD had no effect on ICa density in 
24-month WT or OE myocytes (Figure 3B). These data show that the 
reduction in ICa in 3-month Cav-3OE myocytes was reversed with 
C3SD, indicating that the effect of the peptide was independent of 
Cav-3 expression level, and that Cav-3 dependent regulation of ICa 
decreased with age.
Age was associated with reduced t-tubular ICa density in WT 
myocytes (Figure 2C). A possible mechanism for this observation is 
an age-dependent reduction in constitutive PKA-induced stimulation 
of t-tubular LTCCs, which is also regulated by Cav-3 (25). We there-
fore used the PKA-inhibitor H-89 to investigate the role of PKA in 
the response to age. The mean current density-voltage relationships 
for ICa recorded in the presence of 20 μmol/L H-89 from 3- and 
24-month WT and Cav-3OE intact myocytes are shown in Figure 
3C and D arranged allow comparison of the effect of genotype in 
3-month (Figure 3C) and 24-month (Figure 3D) myocytes. The same 
data are shown rearranged in Figure 3E and F to allow comparison 
of the effects of age in WT (Figure 3E) and Cav-3OE (Figure 3F) 
myocytes. H-89 decreased ICa density in all groups of cells, regardless 
of age, presence of t-tubules or genotype (Figure 3G, H), demonstrat-
ing constitutive LTCC phosphorylation in both the cell surface and 
t-tubular membranes, in both young and aged myocytes regardless 
of Cav-3 over-expression (Figure 3I, J).
More importantly, in the presence of H-89, Cav-3OE persisted 
in decreasing ICa in intact 3 month, but not in 24-month myocytes, 
while aging decreased ICa in WT, but not in Cav-3OE, myocytes 
(Figure 3C–F). Figures 3I and J also show that ICa density was not 
significantly different at the surface membrane in the four groups of 
myocytes, suggesting that the observed changes in ICa occurred in 
the t-tubules (cf. Figure 3G, H). These changes were similar to those 
observed in the absence of H-89 (Figure 2), which suggests that the 
effects of Cav-3OE on ICa were not due solely to differences in PKA-
dependent phosphorylation.
Effect of Aging and Cav-3OE on Protein Expression
To investigate whether compensatory protein changes in the trans-
genic mice might account for these effects, we performed a prote-
omic analysis of myocytes from WT and OE mice (Figure 4A). These 
data showed altered expression in only two proteins: Cav-3 and 
Heat Shock Protein β1 (HSPβ1) increased by 2.9-fold (p < .01) and 
by 1.6-fold (p < .05), respectively. The mechanism underlying the 
increased expression of HSPβ1 is unclear. Expression of Cav-3 and 
LTCC was examined by western blotting in 3- and 24-month WT 
and OE myocytes (Figure 4B, C). Cav-3 expression was ~2.5-fold 
greater in OE myocytes compared with WT cells at both ages, and 
aging was associated with 35% and 22% decreases in Cav-3 ex-
pression in WT and Cav3-OE myocytes, respectively. Despite the 
age-related decrease in Cav-3 expression in Cav-3OE myocytes, the 
level of expression of Cav-3 in 24-month Cav-3OE cells was greater 
Figure  3. Effect of inhibition of Cav-3 and PKA on ICa density in 3- and 
24-month myocytes. (A) Mean ICa density at 0 mV in the absence (−) and 
presence (+) of C3SD peptide in wild-type (WT) and Cav-3OE myocytes for 
myocytes from 3-month-old mice (two-way ANOVA: C3SD ns, genotype 
ns, interaction p < .001). (B) Corresponding data for 24-month-old mice 
(two-way ANOVA: C3SD ns, genotype ns, interaction ns). **p < .01 and 
***p < .001 Bonferroni corrected post-hoc test. White text on bars in A and 
B represent sample sizes (n/N). (C) Mean ICa density-voltage relationships 
recorded in the presence of H-89 from intact 3-month WT (black circles) and 
Cav-3OE myocytes (gray squares). Two-way repeated measures analysis 
of variance (RM ANOVA): voltage p < .001, genotype p < .05, interaction 
p < .001. (D) Corresponding data for 24-month myocytes. Two-way RM 
ANOVA: voltage p < .001, genotype ns, interaction p < .01. (E and F) Data 
presented in C and D, rearranged to compare within (E) WT (two-way RM 
ANOVA: voltage p < .001, age p < .001, interaction p < .001), or (F) Cav-
3OE (two-way RM ANOVA: voltage p < .001, age ns, interaction ns) mice. 
(G, H) Effect of PKA inhibition on mean ICa density at 0 mV in the absence 
(−, from Figure 2) and presence (+) of H-89 measured in intact or DT cells 
from 3-month and 24-month WT (G) and Cav-3OE (H) mice. Sample sizes 
for intact cells/hearts in control solution and in the presence of H-89 are 
provided in Figures 2 and 3, respectively. For DT myocytes, n/N were: WT 
3 month = 8/3; 24 months = 6/3; Cav-3OE 3 months = 7/2; 24 months = 7/2). 
*p < .05, **p < .01, and ***p < .001, Bonferroni corrected post-hoc test. 
(I) Calculated ICa density at 0 mV for the whole cell, surface, or t-tubular 
membranes in WT myocytes in the presence of H-89. (J) Corresponding 
data for Cav-3OE myocytes. *p < .05, **p < .01, and ***p < .001, Student’s 
t test.
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than that in 3-month WT cells (p < .05). However, Cav-3OE did not 
alter the expression of the LTCC α1c-subunit at either age. Although 
mean LTCC expression appeared to decrease by ~15% with age in 
both groups, this was not statistically significant.
The effect of Cav-3 over-expression on Cav-3 protein local-
ization was examined by immunocytochemistry in WT and OE 
myocytes of both ages (Figure 5A). Cav-3 staining was observed 
at the surface of the cell and in regular, transverse striations with 
a periodicity of ~1.8 μm, near RyR staining (lower panels), which 
supports the idea that the majority of Cav-3 antigenicity is at the 
sarcolemmal membranes (including t-tubules). The intensity of 
the sarcolemmal Cav-3 labeling decreased from the cell surface 
to the interior in all groups (Figure 5B). This gradient was more 
pronounced in Cav-3OE myocytes at both ages than in the cor-
responding WT myocytes, suggesting a modest (~10%) decrease 
in the relative amount of Cav-3 staining at the t-tubules com-
pared to the surface. There were no changes in RyR labeling due 
to age or genotype (Figure 5C). Using RyR labeling as a marker 
of the z-disc (since its distribution was not altered between 
groups), colocalization of Cav-3 with RyR labeling tended to re-
duce with Cav-3 over-expression: from 68 ± 2% (n/N = 15/3) to 
58 ± 3% (n/N = 19/3) in 3-month cells and 62 ± 2% (n/N = 18/3) 
to 59 ± 2% (n/N = 23/3) in 24-month cells (data not shown, p < 
.05, two-way ANOVA). These data suggest that Cav-3OE may be 
associated with a mildly altered Cav-3 localization (particularly 
in 3-month myocytes).
SR Ca Release, the Systolic Ca Transient and SR Ca 
Content
Whole-cell Ca transients recorded from field-stimulated (0.1, 0.2, 
and 1.0 Hz) myocytes showed only modest changes in Ca transient 
amplitude and time course with age and Cav-3 over-expression 
(Supplementary Figures S2A and S2B). There were also no marked 
differences in time-to-peak or time-to-half decay between groups: all 
demonstrated the characteristic reduction in duration with increas-
ing stimulation frequency, although the Cav-3OE groups show 
slightly longer durations (Supplementary Table 3).
Closer examination of Ca release near t-tubules using simul-
taneous measurement of membrane potential and intracellular 
Ca also revealed little difference between groups (Supplementary 
Figure S2C). The upper panels of Supplementary Figure S2C 
shows the rising phase of Ca transients scanned along the line 
of a t-tubule in representative myocytes from 3- (left panels) 
and 24-month (right panels) WT and Cav-3OE myocytes. Lower 
panels show the time of AP upstroke (yellow), initiation of Ca 
release (red), and maximum rate of rise of Ca (green). Latency 
to the initiation (Supplementary Figure S2D) or maximum rate 
(Supplementary Figure S2E) of Ca release were not altered by 
age, nor by Cav-3OE. The heterogeneity of Ca release (the dis-
persion, or standard deviation of Ca release latencies) was also 
unaltered (Supplementary Figure S2F). The amplitude of the Ca 
release induced by rapid application of caffeine (10 mM), an index 
of SR Ca content, was not significantly different between 3 and 
24  months in WT (∆F/F0  =  3.6  ±  0.2, n/N  =  16/3 vs 3.4  ±  0.3, 
n/N = 20/3) or Cav-3OE myocytes (∆F/F0 = 3.2 ± 0.3, n/N = 15/3 
vs 4.1 ± 0.4, n/N = 9/3), or between genotypes. Thus, it appears 
Figure 4. Changes in protein expression with age and Cav-3 over-expression. 
(A) Proteomic analysis of cell lysates from 3 months wild-type (WT) and Cav-
3OE mice. Proteins with expression altered in excess of ±20% (marked by 
vertical dashed lines) are labeled: Cav-3, Heat Shock Protein β1 (HSPβ1) and 
mitochondrial (m) NADP transhydrogenase. Horizontal dashed line indicates 
limit of statistical confidence (p < .05). (B) Representative Western blots and 
mean data for Cav-3 protein expression. (C) Representative Western blots 
and mean data for LTCC protein expression. Mean densities are expressed 
normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and 
3-month WT and sample sizes are shown within the bars. ** indicates p < 
.01, Student’s t test.
Figure 5. Cav-3 and RyR protein localization in cardiac myocytes with age 
and Cav-3OE. (A) Representative images of Cav-3 (red) and RyR (green) 
labeling in 3- or 24-month-old cells from wild-type (WT) or Cav-3OE mice. 
Scale bar indicates 10  μm. The graphs show sarcolemmal (including 
t-tubules) Cav-3 (B) or RyR (C) normalized staining intensity as a function 
of distance from the surface sarcolemma. *p < .05 and ***p < .001 by 
two-way analysis of variance for differences between WT and Cav-3OE.
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that the observed changes in t-tubular ICa are accompanied by only 
modest changes in Ca handling.
Discussion
The present study shows, for the first time, that the reduction in 
ICa density of male ventricular myocytes with age occurs predom-
inantly at the t-tubules. The study is also the first to investigate the 
involvement of t-tubule structure and function, and the role of Cav-
3, in aging. In addition to the decreased t-tubular ICa density with 
age, the major findings of the present study were that: (i) although 
Cav-3OE augmented Cav-3 expression in both age groups, it did not 
prevent the reduction of Cav-3 expression with age; (ii) despite large 
decreases in Cav-3 expression with age, changes in t-tubule organ-
ization and Cav-3 localization were modest; (iii) age-dependent cel-
lular hypertrophy was not ameliorated by transgenic overexpression 
of Cav-3; (iv) overexpression of Cav-3 reduced t-tubular ICa density 
at 3-mo, and removed the age-dependent reduction in ICa so that 
the current was maintained at 24-mo; (v) in contrast to 3 months, 
at 24 months, ICa did not appear to be Cav-3 dependent, as demon-
strated by the lack of effect of Cav-3OE and application of C3SD; 
and (vi) neither aging nor Cav-3OE appeared to have pronounced 
effects on Ca release at steady state.
Cav-3 Expression and Localization
Cav-3 protein expression was reduced with age in WT myocytes 
(Figure  4B), consistent with previous reports in mice (28,29), al-
though localization of Cav-3 staining at the t-tubules did not change 
with age. Cav-3OE did not prevent age-dependent loss of Cav-3 al-
though, as might be expected, Cav-3 expression was increased at 
both ages above that seen in 3-month WT (31). However, Cav-3OE 
resulted in a steeper drop in Cav-3 staining intensity from surface 
sarcolemma to t-tubules, suggestive of a partial disruption of Cav-3 
protein association with the t-tubules. Alternatively, the steeper drop 
in staining intensity from surface to interior in Cav-3OE might be a 
result of the preferential localization of overexpressed Cav-3 to the 
surface membrane. The degree of colocalization of Cav-3 with RyR 
labeling appears large compared to that reported by others (36,37). 
However, in the present study, RyR labeling was used simply as a 
marker for the z-disc. Due to microscope blurring, the analysis of 
relatively un-processed confocal microscopy data in the present 
study would have over-estimated the absolute colocalization. Thus, 
the present study is not inconsistent with the previous studies of 
Scriven et al. (2005) and Wong et al. (2013) (36,37). Nevertheless, 
our simple, but straight-forward, approach enables comparison of 
Cav-3 protein localization between groups (ie, age and genotype).
Cell Morphology and t-Tubule Capacitance
Age was associated with cellular hypertrophy and reduction in 
expression of Cav-3, consistent with previous studies (1,28,29). 
Loss-of-function mutations and knockout of Cav-3 are also associ-
ated with cardiac hypertrophy, consistent with a role for loss of 
Cav-3 expression in age-related hypertrophic signaling (38,39). 
However, in this study, the age-dependent hypertrophy was greater 
in myocytes from Cav-3OE than WT mice, demonstrating that 
the hypertrophy was increased, and not ameliorated, by overex-
pression of Cav-3. Nevertheless, the data are consistent with the 
involvement of Cav-3 in hypertrophic signaling pathways in car-
diac myocytes (20–22). Presumably, due to the intimate involve-
ment of Cav-3 in hypertrophic signaling pathways, either loss or 
gain of Cav-3 function can cause hypertrophy. For example, the 
hypertrophic cardiomyopathy caused by knockout of Cav-3 was 
associated with loss of caveolae and increased p42/p44 MAPK sign-
aling (39) whereas the cardiac-specific transgenic overexpression of 
Cav-3, as used in the present study, results in increased numbers of 
caveolar signalsomes (31).
Age was also associated with an increase in the fraction of the 
membrane in the t-tubules in both genotypes determined using cell 
capacitance (Figure 1), while imaging data revealed only a modest 
reduction in t-tubule density with age (Figure 1). The apparent dis-
crepancy cannot be explained by differences in DT efficiency (see 
Methods section). However, while at 3 months, DT cell size was not 
markedly different from that of intact cells in either WT or Cav-
3OE cells, 24-month DT cells were smaller than their intact coun-
terparts (Figure 1, Supplementary Tables S1 and S2). Cell sizes from 
DT cells provide a measure of the surface sarcolemmal membrane 
capacitance. Considering Laplace’s Law, the greater wall stress 
caused by the formamide-induced osmotic shock in hypertrophied 
cells at 24  months compared with the smaller 3-month cells may 
have resulted in increased death of the larger cells and thus selected 
smaller cells in the 24-month group. Given the larger dimensions of 
WT and Cav-3OE myocytes at 24 months compared with 3 months, 
the model predicted a 22% increase in total membrane area with 
age for WT myocytes and a 55% increase in total membrane area 
for Cav-3OE cells in the absence of any change in t-tubule density, 
which agrees well with the observed increase in cell capacitance with 
age (24% and 55%, Figure 1 and Supplementary Table S2). The cor-
responding fraction of membrane in the t-tubules for 24-month WT 
myocytes was 45%, which also agrees well with experimental data 
(52%, Figure 1 and Supplementary Table S2). A similar analysis for 
changes in Cav-3OE myocytes with age revealed a 55% increase 
in total membrane area and a fraction of membrane that is in the 
t-tubules of 42%, which also agree well with those obtained experi-
mentally (55% and 45%, respectively, Figure 1 and Supplementary 
Table S2). Taken together, these data suggest little change in t-tubule 
structure with age or with over-expression of Cav-3. Although Cav-3 
has been implicated in the development of t-tubules and the cardiac-
specific overexpression of Cav-3 has previously been reported to in-
crease numbers of caveolae in heart muscle (19,31,40), it is striking 
that in the present study overexpression of Cav-3 had no effect on 
t-tubule morphology. Presumably other structural proteins, such as 
BIN-1, are also required for t-tubule development (41).
Over-estimation of t-tubule capacitance due to small DT 
24-month myocytes might lead to under-estimation of t-tubular 
ICa density. However, applying the model described above to cor-
rect t-tubular ICa and capacitance results in little change in the data: 
in 3-month cells, the calculated t-tubular ICa density is unchanged 
(compare Supplementary Table S1 to Figure 2C), and in 24-month 
cells, the corrected t-tubular ICa density for WT and OE myocytes 
is −8.2 ± 0.9 and −10.1 ± 1.2 pA/pF, respectively (Supplementary 
Table S1). Thus, the interpretation of the data is unchanged: age sig-
nificantly decreases t-tubular ICa density in WT (−41%, p < .01), but 
not in OE (ns, t test). Such consideration of the effect of cell size on 
t-tubular membrane fraction and current densities may be important 
in any investigation of interventions that cause changes of cell size 
and has not, to our knowledge, been considered previously.
Distribution and Regulation of ICa
The present study shows that the age-dependent decrease in ICa 
density occurs primarily at the t-tubules (Figure 2) and is associated 
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with a decrease in Cav-3 expression (Figure  4). Cav-3 has previ-
ously been shown to associate with LTCC and elements of the β2-
adrenergic/cAMP-dependent pathway at the t-tubule and mediate 
PKA-dependent constitutive stimulation of t-tubular ICa (25,27,42). 
Pretreatment of cells with C3SD peptide reduced ICa density in 
3-month WT, but not in 24-month WT cells (Figure 3), suggesting 
that the reduction in ICa density with age is associated with the loss 
of a Cav-3-dependent mechanism that augments t-tubular ICa dens-
ity. However, the decrease of ICa density was not a consequence of 
reduced constitutive PKA-dependent stimulation of ICa with age, 
because application of H-89 caused a robust decrease in whole-cell 
and t-tubular ICa density in both 3-month (−62% and −58%, respect-
ively) and 24-month (−64% and −59%, respectively) cells. Nor was 
the age-dependent decrease in ICa density a consequence of reduced 
LTCC expression (Figure 4). Age has been associated with redistri-
bution of Cav-3 from cholesterol-rich to cholesterol-free membranes 
in heart muscle, indicating a loss of caveolin from caveolae with age 
(43). This redistribution may underlie the apparent loss of associ-
ation of Cav-3 with LTCC and the cAMP signaling pathway in the 
t-tubule membrane in 24-month myocytes so that the constitutive 
regulation of ICa became insensitive to C3SD but retained sensitivity 
to PKA inhibition. However, localization of Cav-3 to the t-tubules 
was not reduced with age (Figure 5). Moreover, the age-dependent 
reduction in ICa density was associated with an increased total mem-
brane area and an increased fraction of membrane in the t-tubules 
(Supplementary Table S2 and Supplementary Figure S1).
Over-expression of Cav-3 was associated with reduced t-tubular 
ICa density in 3-month myocytes, suggesting that ICa is decreased by 
either inhibition or overexpression of Cav-3, and consistent with a 
role for Cav-3 in determining basal t-tubule ICa density in myocytes 
from young animals (25). The reduction of ICa caused by OE was not 
due to a decrease in LTCC expression (Figure 4), but might reflect 
slightly less constitutive PKA stimulation of ICa since application of 
H-89 to 3-month Cav-3OE cells was associated with a smaller reduc-
tion in whole-cell (−56%) and t-tubular (−47%) ICa compared to WT 
(see Figure 3G, H). A possible explanation is that Cav-3OE resulted 
in mis-location of a fraction of the protein that, in consequence, was 
unable to perform its native task(s) but competed for binding part-
ners with normally-located Cav-3. This idea is consistent with the 
observation that application of C3SD peptide increases ICa density in 
3-month Cav-3OE myocytes (Figure 3). Imaging data also showed 
that there may be some relocation of Cav-3 with over-expression, as 
Cav-3OE cells showed reduced relative Cav-3 staining intensity at 
the t-tubules (Figure 5).
Interestingly, in contrast to the decrease observed in WT myo-
cytes, there was no change in whole cell or t-tubular ICa density during 
aging in Cav-3OE myocytes (Figure 2). The preservation of ICa dens-
ity at the t-tubules in 24-month Cav-3OE myocytes occurs despite a 
77% increase in t-tubular surface area due to age-dependent hyper-
trophy. This suggests maintenance of t-tubular ICa as a result of Cav-3 
overexpression. Despite the reduction in Cav-3 expression with age 
in Cav-3OE myocytes, expression of the protein remained approxi-
mately twofold greater than in 3-month WT myocytes (Figure 4). 
Thus, the data are consistent with the proposal that overexpression 
of Cav-3 protected against the age-dependent loss of LTCC func-
tion from the t-tubules. Nevertheless, Cav-3 staining intensity at the 
t-tubules appeared reduced compared to 24-month WT myocytes 
(Figure 5), suggesting disruption of Cav-3 localization in 24-month 
Cav-3OE cells. The mechanism by which Cav-3 over-expression pro-
tected against the age-dependent loss of t-tubular ICa remains unclear. 
H-89 caused a similar decrease in ICa density in 24-month WT and 
OE myocytes (Figure 3), suggesting that the reduced Cav-3 expression 
with age in Cav-3OE was sufficient to alleviate the small inhibitory 
effect of overexpression on the Cav-3/PKA-dependent pathway that 
was evident at 3 months. This is consistent with the results obtained 
in the presence of C3SD, which showed no effect on ICa in 24-month 
Cav-3OE cells (Figure 3). In any case, while H-89 reduced whole-cell 
and t-tubule ICa density in both 3-month and 24-month Cav-3OE 
cells, there was no difference in current densities between the two 
ages, indicating that the protective effect of Cav-3 over-expression 
against age-dependent loss of t-tubular ICa was independent of con-
stitutive regulation by PKA.
Excitation-Contraction Coupling
The ~50% decrease in t-tubular ICa density with age was not asso-
ciated with altered Ca release at the t-tubule in the present study: 
latency between action potential upstroke and Ca release, hetero-
geneity of Ca release along the t-tubule and Ca transient properties 
were not significantly affected by age (Supplementary Figure S2 and 
Supplementary Table S3). This is consistent with previous studies 
that have shown no age-dependent differences in Ca transient ampli-
tude or duration when cells were stimulated at frequencies similar to 
those used in the present study, although at higher frequencies the Ca 
transient may be smaller and slower with age (9,44). There were no 
changes in RyR distribution (Figure 5), LTCC expression (Figure 4), 
or SR Ca content. Thus, the unaltered Ca release may be explained 
by: (i) the highly nonlinear relationship between ICa and SR Ca re-
lease (45,46) so that there is effectively a functional reserve in ICa; (ii) 
since a significant proportion of LTCCs are located outside the dyad, 
reduction in ICa density in this population would have little effect 
on CICR. The former is supported by the observation that absolute 
t-tubular ICa is unaltered while fractional t-tubule area increased in 
myocytes from old animals (Supplementary Table S2), in contrast 
to the decrease in absolute t-tubular ICa with no change in t-tubular 
membrane area observed in heart failure (26). The latter is supported 
by recent evidence of a role for Cav-3 in the regulation of nondyadic 
LTCC in cardiac muscle (47,48).
Supplementary Material
Supplementary data is available at The Journals of Gerontology, 
Series A: Biological Sciences and Medical Sciences online.
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